… cell infiltration and marked pro-inflammatory cytokine responses induced by SARS-CoV and
… , there seem to be gender differences in vulnerability and mortality to SARS-CoV-2 infection […

… COVID-19-induced ARDS. We are the first to exclusively characterize a COVID-19 ICU patient
population with an expected mortality … to the production of pro-inflammatory cytokines (ie IL…

… COVID-19 related CS (20). CS is characterised by elevated serum levels of pro-inflammatory
cytokines … COVID-19 mortality rates in males are twice that of females [69]. Similar data on …

… is the leading cause of mortality for COVID-19 patients (5). Hypercytokinemia, which is
also called … Both anti-inflammatory cytokines (such as IL-10 and IL-13) and pro-inflammatory …

… line of defensive mechanism against virus infection, subsequently triggering the expressions
of pro-inflammatory cytokines including IL-1 and TNF-α [42]. Excessive production of those …

… inflammation and associated mortality in COVID-19. SPMs … may not be sufficient to prevent
COVID-19 progression. … by COVID-19, by broadly inhibiting pro-inflammatory cytokine …

… mortality from COVID-19. An attempt to understand the pathophysiology of various hematological
abnormalities including cytokine … pro-inflammatory soluble mediators called cytokines …

… pro-inflammatory cytokines are also seen in bacterial sepsis. This study aimed to assess the
clinical utility of a cytokine panel in the assessment of COVID-19 … mortality rate in COVID-19 […

… risk factors for COVID-19 mortality and aims to establish a COVID-19 mortality risk prediction
model … might be implicated in the induction of proinflammatory cytokines, although the exact …

… outcomes and mortality in COVID-19 patients [19], and the IL-6 receptor antagonists such
as tocilizumab may reduce 28-day all-cause mortality in hospitalized patients with COVID-19 […